SILVERCREST ASSET MANAGEMENT GROUP LLC - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 15 filers reported holding Astellas Pharma Inc in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SILVERCREST ASSET MANAGEMENT GROUP LLC ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q2 2022$1,757,000
-0.8%
112,833
+0.2%
0.01%
+8.3%
Q1 2022$1,772,000
-3.6%
112,575
-0.5%
0.01%0.0%
Q4 2021$1,838,000
+0.8%
113,135
+2.4%
0.01%0.0%
Q3 2021$1,824,000
-5.0%
110,460
+0.3%
0.01%
-7.7%
Q2 2021$1,920,000
+13.0%
110,145
-0.2%
0.01%
+18.2%
Q1 2021$1,699,000
+18.0%
110,330
+18.3%
0.01%0.0%
Q4 2020$1,440,000
+42.9%
93,260
+37.4%
0.01%
+22.2%
Q3 2020$1,008,000
-15.6%
67,895
-5.2%
0.01%
-18.2%
Q2 2020$1,195,00071,6300.01%
Other shareholders
Astellas Pharma Inc shareholders Q2 2020
NameSharesValueWeighting ↓
RENAISSANCE GROUP LLC 469,618$7,628,0000.31%
TODD ASSET MANAGEMENT LLC 193,500$3,148,0000.07%
SCOUT INVESTMENTS, INC. 225,247$3,665,0000.05%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 193,500$3,148,0000.03%
SILVERCREST ASSET MANAGEMENT GROUP LLC 113,135$1,838,0000.01%
Private Capital Group, LLC 924$15,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 35$1,0000.00%
IFP Advisors, Inc 40$1,0000.00%
First Horizon Advisors, Inc. 120$1,0000.00%
CAPTRUST FINANCIAL ADVISORS 3,790$62,0000.00%
View complete list of Astellas Pharma Inc shareholders